Jairoun Ammar Abdulrahman, Al-Hemyari Sabaa Saleh, Shahwan Moyad, Alkhoujah Sahab, El-Dahiyat Faris, Jaber Ammar Ali Saleh, Zyoud Sa'ed H
Health and Safety Department, Dubai Municipality, Dubai, United Arab Emirates.
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Pulau Pinang 11500, Malaysia.
Explor Res Clin Soc Pharm. 2025 Feb 6;17:100576. doi: 10.1016/j.rcsop.2025.100576. eCollection 2025 Mar.
The current study aimed to investigate how regulatory frameworks and policies are used to support the use of sustainable medicines within the pharmaceutical sector.
The Scopus database was searched to retrieve papers. Advanced search tool of the Scopus online database was used focused on the papers that have the search query included in their titles. Data analysis incorporated bibliometric indicators like publication counts and trends, visualized through VOSviewer software version 1.6.20.
A total of 43 publications on Sustainable Medicines Use were found between 2000 and 2024. Leading countries in publication output on sustainable medicines use were United Kingdom, United States, India, Italy, Portugal, and Switzerland, indicating their collaborative relationships and publication volumes. A total of 92 institutions have been involved in research on Sustainable Medicines Use. Key institutions such as the Faculty of Engineering and the Laboratory for Process and Environmental Engineering, Lowell Center for Sustainable Production, Greiner Environmental Inc., and the University of Florence are prominently featured, indicating their significant contributions to research in this area. Key journals such as the "Journal of Cleaner Production," "Business Strategy and the Environment," "Chemical Engineering Transactions," "Benchmarking," and "Lecture Notes in Mechanical Engineering" are prominently featured. The retrieved articles have been cited an average count of 22.26. The overlay visualization created using VOSviewer suggest a shift towards exploring new drug categories, innovative approaches, and the commercial aspects of sustainability. Future research directions are likely to delve deeper into innovative methods and sustainable chemical practices (green chemistry), reflecting an emphasis on developing greener processes and products.
This study offers a thorough analysis of the legislative and governmental strategies promoting the use of sustainable medicine. It offers important insights for promoting sustainability in the pharmaceutical industry by pointing out gaps, defining useful frameworks, and suggesting doable solutions. Achieving sustainable pharmaceutical practices that support worldwide environmental and public health objectives requires sustained research, policy development, and international cooperation. The area needs to keep developing and implementing sustainable methods like green chemistry to decrease environmental harm and improve sustainability. Furthermore, collaborations among academia, industry, and international organizations are essential to progress and interchange effective strategies.
当前研究旨在调查监管框架和政策如何用于支持制药行业内可持续药物的使用。
检索Scopus数据库以获取论文。使用Scopus在线数据库的高级搜索工具，重点关注标题中包含搜索查询的论文。数据分析纳入了文献计量指标，如发表数量和趋势，并通过VOSviewer 1.6.20软件进行可视化。
2000年至2024年间，共发现43篇关于可持续药物使用的出版物。在可持续药物使用方面发表成果领先的国家有英国、美国、印度、意大利、葡萄牙和瑞士，这表明了它们之间的合作关系和发表量。共有92个机构参与了可持续药物使用的研究。工程学院、过程与环境工程实验室、洛厄尔可持续生产中心、格雷纳环境公司和佛罗伦萨大学等关键机构表现突出，表明它们对该领域研究的重大贡献。《清洁生产杂志》《商业战略与环境》《化学工程学报》《标杆管理》和《机械工程讲义》等关键期刊表现突出。检索到的文章平均被引用22.26次。使用VOSviewer创建的叠加可视化表明，研究正朝着探索新药物类别、创新方法和可持续性的商业方面转变。未来的研究方向可能会更深入地探讨创新方法和可持续化学实践（绿色化学），这反映出对开发更绿色工艺和产品的重视。
本研究对促进可持续药物使用的立法和政府战略进行了全面分析。它通过指出差距、定义有用的框架并提出可行的解决方案，为促进制药行业的可持续性提供了重要见解。要实现支持全球环境和公共卫生目标的可持续制药实践，需要持续的研究、政策制定和国际合作。该领域需要不断开发和实施绿色化学等可持续方法，以减少环境危害并提高可持续性。此外,学术界、产业界和国际组织之间的合作对于推进和交流有效战略至关重要。
